|
Volumn 19, Issue 7-8, 2000, Pages 680-683
|
Long term persistence of anti-HBs protective levels in young patients with type 1 diabetes after recombinant hepatitis B vaccine
|
Author keywords
Hepatitis B; Hepatitis B vaccination; Immune response
|
Indexed keywords
HEPATITIS B SURFACE ANTIBODY;
RECOMBINANT HEPATITIS B VACCINE;
ADULT;
ANTIBODY TITER;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HEPATITIS B;
HUMAN;
IMMUNE RESPONSE;
INSULIN DEPENDENT DIABETES MELLITUS;
MAJOR CLINICAL STUDY;
MALE;
PERIPHERAL NEUROPATHY;
PERSISTENT VIRUS INFECTION;
PRIORITY JOURNAL;
RETINOPATHY;
SCHOOL CHILD;
VACCINATION;
ADOLESCENT;
ADULT;
CASE-CONTROL STUDIES;
CHILD;
DIABETES MELLITUS, TYPE 1;
FEMALE;
FOLLOW-UP STUDIES;
HEPATITIS B;
HEPATITIS B ANTIBODIES;
HEPATITIS B VACCINES;
HUMANS;
MALE;
TIME FACTORS;
VACCINES, SYNTHETIC;
|
EID: 0034703830
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(00)00268-1 Document Type: Article |
Times cited : (25)
|
References (26)
|